Ross Levine

Ross Levine

Director/Board Member chez QIAGEN N.V.

Fortune : 716 483 $ au 31/03/2024

52 ans
Health Technology
Consumer Services
Health Services

Profil

Ross L.
Levine
is the founder of Ajax Therapeutics, Inc. (founded in 2019) where he holds the title of Director.
He is currently working as an Independent Director at Medicus Sciences Acquisition Corp.
since 2021, as an Independent Member-Supervisory Board at QIAGEN NV since 2016, as a Member-Supervisory Board at QIAGEN GmbH, as a Professor at Weill Cornell Medical College since 2007, and as a Member-Supervisory Board at QIAGEN Srl.
Dr. Levine has previously worked as the Chief-Molecular Cancer Medicine Services at Memorial Sloan Kettering Cancer Center from 2018 to 2022 and as a Scientific Advisor at eFFECTOR Therapeutics, Inc. Dr. Levine holds a doctorate degree from The Johns Hopkins University School of Medicine and an undergraduate degree from Harvard College.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
29/02/2024 16 738 ( 0,01% ) 716 483 $ 31/03/2024

Postes actifs de Ross Levine

SociétésPosteDébut
QIAGEN N.V. Director/Board Member 01/01/2016
MEDICUS SCIENCES ACQUISITION CORP. Director/Board Member 12/02/2021
Director/Board Member -
Weill Cornell Medical College Corporate Officer/Principal 01/01/2007
Director/Board Member -
Founder 01/01/2019
Tous les postes actifs de Ross Levine

Anciens postes connus de Ross Levine

SociétésPosteFin
Corporate Officer/Principal -
EFFECTOR THERAPEUTICS, INC. Corporate Officer/Principal -
Voir l'expérience en détail de Ross Levine

Formation de Ross Levine

The Johns Hopkins University School of Medicine Doctorate Degree
Harvard College Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Ross Levine

Relations

100 +

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
QIAGEN N.V.

Health Technology

EFFECTOR THERAPEUTICS, INC.

Health Technology

Entreprise privées5

Health Services

Commercial Services

Health Technology

Health Technology

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Ross Levine